What is the suggested weekly dosage of semaglutide for obesity management?

The suggested weekly dosage of semaglutide for obesity management is 2.4 mg. Semaglutide, originally developed for the treatment of type 2 diabetes, has been shown in clinical trials to be effective for weight management at this higher dose. The 2.4 mg weekly dosage allows for significant weight loss while maintaining safety and tolerability for patients struggling with obesity.

Dosing at this level is vital, as it has been associated with the maximum therapeutic benefits in terms of weight reduction, intending to help individuals achieve meaningful weight loss and improve associated comorbidities. Other dosages, while they may be relevant in different contexts or for different patient populations, do not represent the maximum effective dose for obesity management as established in clinical guidelines and studies.